new_adrs_0322_1341|XLO|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_adrs_0322_1341|XLO|Long Name|1|1|Xilio Therapeutics Inc Total Current Assets (Quarterly) (USD)|Xilio Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Xilio Therapeutics Inc Inventories (Quarterly) (USD)|Xilio Therapeutics Inc Net PP&E (Quarterly) (USD)|Xilio Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Xilio Therapeutics Inc Total Liabilities (Quarterly) (USD)|Xilio Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Xilio Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Xilio Therapeutics Inc Total Deposits (Quarterly) (USD)|Xilio Therapeutics Inc Book Value (Quarterly) (USD)|Xilio Therapeutics Inc Retained Earnings (Quarterly) (USD)|Xilio Therapeutics Inc Treasury Stock (Quarterly) (USD)|Xilio Therapeutics Inc EV to Revenues|Xilio Therapeutics Inc EV to Earnings|Xilio Therapeutics Inc EV to Free Cash Flow|Xilio Therapeutics Inc EV to Assets (Quarterly)|Xilio Therapeutics Inc PS Ratio|Xilio Therapeutics Inc PE Ratio|Xilio Therapeutics Inc Price to Book Value|Xilio Therapeutics Inc PEG Ratio|Xilio Therapeutics Inc Debt to Equity Ratio|Xilio Therapeutics Inc Dividend Yield|Xilio Therapeutics Inc Shareholder Yield (TTM)|Xilio Therapeutics Inc Percent of Shares Outstanding Short|Xilio Therapeutics Inc Total Receivables (Quarterly) (USD)|Xilio Therapeutics Inc Total Payables (Quarterly) (USD)|Xilio Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Xilio Therapeutics Inc Return on Invested Capital|Xilio Therapeutics Inc Quality Ratio Score|Xilio Therapeutics Inc Momentum Score|Xilio Therapeutics Inc Beta (1Y)|Xilio Therapeutics Inc Sustainable Growth Rate (TTM)|Xilio Therapeutics Inc Institutional Investor Ownership Percentage|Xilio Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Xilio Therapeutics Inc Total Employees (Annual)|Xilio Therapeutics Inc EPS Diluted (Quarterly) (USD)|Xilio Therapeutics Inc Shares Outstanding|Xilio Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Xilio Therapeutics Inc Ordinary Shares Number (Quarterly)|Xilio Therapeutics Inc Payout Ratio|Xilio Therapeutics Inc Quick Ratio (Quarterly)|Xilio Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Xilio Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Xilio Therapeutics Inc Effective Tax Rate (TTM)|Xilio Therapeutics Inc Return on Equity|Xilio Therapeutics Inc Net Income (TTM) (USD)|Xilio Therapeutics Inc Revenue (TTM) (USD)|Xilio Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Xilio Therapeutics Inc Revenue (Quarterly) (USD)|Xilio Therapeutics Inc Gross Profit (Quarterly) (USD)|Xilio Therapeutics Inc SG&A Expense (Quarterly) (USD)|Xilio Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Xilio Therapeutics Inc Net Income (Quarterly) (USD)|Xilio Therapeutics Inc Net Interest Income (Quarterly) (USD)|Xilio Therapeutics Inc Price (USD)|Xilio Therapeutics Inc Total Return Price (USD)|Xilio Therapeutics Inc Enterprise Value (USD)|Xilio Therapeutics Inc 30-Day Average Daily Volume|Xilio Therapeutics Inc 1 Year Price Returns (Daily)
new_adrs_0322_1341|XLO|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_adrs_0322_1341|XLO||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_adrs_0322_1341|XLO||5|5|121.666666667|121.666666667|0|121.666666667|0|121.666666667|121.666666667|121.666666667|0|121.666666667|121.666666667|0|0|0|0|0|0|0|1.45283018868|0|0|1.45544554455|0|15.25|0|121.666666667|121.666666667|0|0|0|0|0|30|152.333333333|92|152.333333333|23.2|0|121.666666667|0|0|152.333333333|0|0|0|0|0|0|0|0|152.333333333|152.333333333|152.333333333|0|1.45544554455|1.45544554455|1.45544554455|1.45833333333|0
new_adrs_0322_1341|XLO||6|6|3|3|0|3|0|3|3|3|0|3|3|0|0|0|0|0|0|0|53|0|0|101|0|8|0|3|3|0|0|0|0|0|1|3|1|3|5|0|3|0|0|3|0|0|0|0|0|0|0|0|3|3|3|0|101|101|101|72|0
new_adrs_0322_1341|XLO||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_adrs_0322_1341|XLO|202009|202009|202009||||||||||||||||||||||||||||||||||26.666||-0.5557||||||-0.5557|||||||||3.163|-14.819|-14.819||||||
new_adrs_0322_1341|XLO|202012|202012|202012|20.59|19.238||13.676||119.604|22.155|97.449||-83.287|-85.086|||||||||||||||5.444|0|||||||26.666||-0.779|||26.666|||-0.779|||||||||2.928|-20.772|-20.772||||||
new_adrs_0322_1341|XLO|202106|202106|202106|124.586|120.299||13.449||261.333|21.305|240.028||-121.309|-124.934|||||||||||||||8.409|0||||||||||||26.666||||||||||||||||||||
new_adrs_0322_1341|XLO|202109|202109|202109|105.572|99.767||13.173||257.18|12.871|244.309||-136.455|-141.185|||||||||||||||3.822|0|||||||26.666|69|-0.6094|||26.666|||-0.6094|||||||||5.491|-16.251|-16.251||||||
new_adrs_0322_1341|XLO|202110|202109|202109||||||||||||||||||||||0||0.434|||||||||99.9451||||26.666||||||||||||||||||16.79|16.79|357.5351||
new_adrs_0322_1341|XLO|202111|202109|202109||||||||||||||||||||||0||1.401|||||||||96.8622||||27.4689||||||||||||||||||15.84|15.84|344.9204||
new_adrs_0322_1341|XLO|202112|202112|202112|202.517|198.053||13.597||32.631|12.778|19.853||185.429|-160.886||||||||2.3607|||0||1.4654||3.144|0.003|||||||27.3584|74|-0.98|27.3584||27.3584|||-0.98||||-71.543|||||8.204|-19.701|-19.701||16|16|249.3094|178244.7333|
new_adrs_0322_1341|XLO|202201|202112|202112|||||||||||||||||||2.008|||0||0.9116|||||||||||||||||||||||||||||||13.61|13.61|183.9228|98663.3|
new_adrs_0322_1341|XLO|202202|202112|202112|||||||||||||||||||1.7451|||0||0.8334|||||||||||||27.469||||||||||||||||||11.78|11.78|135.1598|30746.6667|
new_adrs_0322_1341|XLO|202203|202203|202203|||||||||||||||||||1.1392|||0|||||||||||||||||||||||||||||||||7.69|7.69|22.8116|27536.4|